OTHER INFORMATION
−Removed: During the three months ended March 31, 2025, no director or officer, as defined in Rule 16a - 1 (f) under the Securities Exchange Act of 1934, as amended, of the Company adopted or terminated a "Rule 10b5 - 1 trading arrangement" or "non-Rule 10b5 - 1 trading arrangement," as each term is defined in Item 408 (a) of Regulation S-K.
+Added: During the three months ended June 30, 2025 , no director or officer, as defined in Rule 16a - 1 (f) under the Securities Exchange Act of 1934, as amended, of the Company adopted or terminated a "Rule 10b5 - 1 trading arrangement" or "non-Rule 10b5 - 1 trading arrangement," as each term is defined in Item 408 (a) of Regulation S-K.
Incorporated by Reference
+Added: Asset Purchase Agreement dated April 22, 2025 by and between the Company and Cardionomic (assignment for the benefit of creditors), LLC
Amended and Restated Certificate of Incorporation of the Registrant.
13 unchanged sentences
Specimen common stock certificate of the Registrant.
−Removed: Form of warrant issued in May 2020.
−Removed: Form of pre-funded warrant issued in May 2020.
−Removed: Form of placement agent warrant issued in May 2020.
−Removed: Form of warrant offered in July 2020.
−Removed: Form of pre-funded warrant issued in July 2020.
−Removed: Form of placement agent warrant offered in July 2020.
−Removed: Form of placement agent warrant offered in October 2024
Form of Series B Warrant offered in February 2022.
3 unchanged sentences
1, dated July 22, 2022, to February 8, 2022 Warrant Agency Agreement by and between the Company and American Stock Transfer & Trust Company, LLC.
−Removed: Form of Series E Warrant offered in January 2023.
−Removed: Form of Series F Warrant issued in March 2023.
−Removed: Form of Series G Warrant issued in March 2023.
−Removed: Form of Series H Common Stock Warrant issued September 2024
Form of Series I common stock Warrant issued September 2024
Form of Series J common stock Warrant issued September 2024
−Removed: Form of Pre-Funded Common Stock Purchase Warrant issued September 2024
Form of Series K Warrant issued October 2024
−Removed: Form of Placement Agent Warrant
+Added: Form of Placement Agent Warrant offered in October 2024
Form of Underwriters' Warrant offered in September 2024
1 unchanged sentence
Form of Series L Warrant offered in May 2025.
−Removed: Non-plan Stock Option Award granted January 6, 2025 to Philip Anderson
−Removed: Offer Letter to Philip Anderson dated January 3, 2025
+Added: Amendment to Investment Banking Agreement dated as of April 16, 2025 entered into by and between the Company and Ladenburg Thalmann & Co.
+Added: At the Market Offering Agreement dated as of May 19, 2025 entered into by and between the Company and Ladenburg Thalmann & Co.
+Added: Securities Purchase Agreement dated May 12, 2025
+Added: Registration Rights Agreement dated May 12, 2025
+Added: Assignment Agreement dated May 12, 2025
+Added: Investment Banking Agreement dated February 11, 2025 entered into by and between the Company and Ladenburg Thalmann & Co.
Certification of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
16 unchanged sentences
CATHETER PRECISION, INC.
+Added: August 11, 2025
Executive Chairman of the Board and
1 unchanged sentence
(Principal Executive Officer)
+Added: August 11, 2025
/s/ Philip Anderson
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.